Home - Products - Others - Other Targets - Cyanidin3-glucopyranosyl-(1-6)-[3-xylopyranosyl-(1-2)]-galactopyranoside

Cyanidin3-glucopyranosyl-(1-6)-[3-xylopyranosyl-(1-2)]-galactopyranoside

CAS No. 142561-98-6

Cyanidin3-glucopyranosyl-(1-6)-[3-xylopyranosyl-(1-2)]-galactopyranoside( ——— )

Catalog No. M39726 CAS No. 142561-98-6

Cyanidin3-glucopyranosyl-(1→6)-[3-xylopyranosyl-(1→2)]-galactopyranoside

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Cyanidin3-glucopyranosyl-(1-6)-[3-xylopyranosyl-(1-2)]-galactopyranoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Cyanidin3-glucopyranosyl-(1→6)-[3-xylopyranosyl-(1→2)]-galactopyranoside
  • Description
    Cyanidin3-glucopyranosyl-(1→6)-[3-xylopyranosyl-(1→2)]-galactopyranoside
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    142561-98-6
  • Formula Weight
    ———
  • Molecular Formula
    ———
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • γ-TAC4 (30 - 61) - N...

    γ-TAC4 (30 - 61) - NH2

  • Auranofin

    Auranofin is an antirheumatic agent, is used to treat rheumatoid arthritis.

  • pep2-SVKI

    Inhibitor peptide corresponding to last 10 amino acids of the C-terminus of the GluA2 AMPA receptor subunit. Disrupts binding of GluA2 (at the C-terminal PDZ site) with glutamate receptor interacting protein (GRIP), AMPA receptor binding protein (ABP) and protein interacting with C kinase (PICK1). Increases amplitude of AMPA receptor-mediated currents and blocks long-term depression (LTD).